Food and Drug Administration approvals in phase 3 Cancer clinical trials

被引：0
|
作者：
Joseph Abi Jaoude
Ramez Kouzy
Marc Ghabach
Roshal Patel
Dario Pasalic
Elie Ghossain
Austin B. Miller
Timothy A. Lin
Vivek Verma
C. David Fuller
Vivek Subbiah
Bruce D. Minsky
Ethan B. Ludmir
Cullen M. Taniguchi
机构：
[1] The University of Texas MD Anderson Cancer Center,
[2] The University of Texas Health Science Center McGovern Medical School,undefined
[3] The Johns Hopkins University School of Medicine,undefined
[4] The University of Texas MD Anderson Cancer Center,undefined
来源：
BMC Cancer | / 21卷
关键词：
Oncology; Clinical trials; FDA; Primary endpoint; Surrogate endpoint; Industry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Food and Drug Administration approvals in phase 3 Cancer clinical trials
    Jaoude, Joseph Abi
    Kouzy, Ramez
    Ghabach, Marc
    Patel, Roshal
    Pasalic, Dario
    Ghossain, Elie
    Miller, Austin B.
    Lin, Timothy A.
    Verma, Vivek
    Fuller, C. David
    Subbiah, Vivek
    Minsky, Bruce D.
    Ludmir, Ethan B.
    Taniguchi, Cullen M.
    [J]. BMC CANCER, 2021, 21 (01)
  • [2] Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (08) : 1108 - 1115
  • [3] Single-arm trials for US Food and Drug Administration cancer drug approvals
    Nierengarten, Mary Beth
    [J]. CANCER, 2023, 129 (11) : 1626 - 1627
  • [4] Core limitations in clinical trials leading to anticancer drug approvals by the US Food and Drug Administration.
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Sex or Gender Reporting in Ophthalmology Clinical Trials Among US Food and Drug Administration Approvals, 1995 to 2022
    Xie, Jim Shenchu
    Kaur, Hargun
    Tao, Brendan
    Lee, Jordon
    Solish, Danielle
    Kohly, Radha
    Margolin, Edward
    [J]. JAMA OPHTHALMOLOGY, 2024, 142 (02) : 123 - 130
  • [6] Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020
    Berkowitz, Sean T.
    Groth, Sylvia L.
    Gangaputra, Sapna
    Patel, Shriji
    [J]. JAMA OPHTHALMOLOGY, 2021, 139 (06) : 629 - 637
  • [7] Timing of US Food and Drug Administration (FDA) cancer drug approvals relative to publication of clinical trial results.
    Khaki, Ali Raza
    Desai, Aakash
    Schoen, Martin W.
    Gyawali, Bishal
    Chen, Eddy J.
    Yang, Peter C.
    Warner, Jeremy Lyle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
    Duranti, Simona
    Fabi, Alessandra
    Filetti, Marco
    Falcone, Rosa
    Lombardi, Pasquale
    Daniele, Gennaro
    Franceschini, Gianluca
    Carbognin, Luisa
    Palazzo, Antonella
    Garganese, Giorgia
    Paris, Ida
    Scambia, Giovanni
    Pietragalla, Antonella
    [J]. CANCERS, 2021, 13 (20)
  • [9] Design analysis indicates Potential overestimation of treatment effects in randomized controlled trials supporting Food and Drug Administration cancer drug approvals
    Lord, Emily M.
    Weir, Isabelle R.
    Trinquart, Ludovic
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2018, 103 : 1 - 9
  • [10] Food and Drug Administration Procedures for New Drug and Device Approvals
    Holland, Gary N.
    Eydelman, Malvina B.
    Cunningham, Brad
    Chambers, Wiley A.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 161 : 1 - 3
12345